Background: Previous studies have shown an association between disruption of the blood-
brain-barrier (BBB) and dementias of different etiologies. The protein concentration of …

A connection between dementias and blood-brain barrier (BBB) dysfunction has been
suggested, but previous studies have yielded conflicting results. We examined …

Background Alterations in the CSF/serum albumin ratio (Qalb) is currently recognized as
one of the most reliable markers of blood–brain barrier impairment and blood-CSF barrier …

Blood-brain barrier (BBB) dysfunction might be an important component of many
neurodegenerative disorders. In this study, we investigated its role in dementia using large …

Introduction Inflammation is an important player in Alzheimer's disease (AD), whose effects
can be influenced by the blood–brain barrier (BBB). Here, we investigated the relationship …

Abstract Background/Aims: Alterations in the blood-brain barrier (BBB) may play an
important role in the pathogenesis and treatment of Alzheimer's disease (AD). We …

The role of blood-cerebrospinal fluid barrier (BCB) dysfunction in Alzheimer's disease (AD)
has been addressed but not yet established. We evaluated the BCB integrity in 179 samples …

Background Blood brain barrier (BBB) breakdown is considered a potential mechanism of
dementia. The Alzheimer's disease (AD) biomarkers and vascular factors are also …

Background The cerebrospinal fluid (CSF)/serum quotient of albumin (QAlb) is the most
used biomarker for the evaluation of blood–cerebrospinal fluid barrier (B-CSF-B) …

Blood-brain barrier (BBB) permeability can be measured by the ratio of albumin in
cerebrospinal fluid (CSF) and blood and by dynamic contrast-enhanced MRI (DCEMRI) …